CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 132 enrolled
Drug / intervention
Restylane Perlanedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02216851
NCT02216851N/ACompleted

A Randomized, Open Label, No-treatment Controlled, Multi-center, Efficacy and Safety Study Using Restylane Perlane to Shape the Nasal Dorsum and/or Nasal Root

Galderma R&D·interventional·Posted Aug 15, 2014·Updated Aug 26, 2022

In Brief

A clinical study evaluating Restylane Perlane for Nasal Augmentation. Completed, enrolled 132 participants across 2 sites.

Detailed Summary

The purpose of this study is to determine the safety and efficacy of using Restylane Perlane to shape the nasal dorsum and/or nasal root in comparison with a no-treatment control group

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedAug 15, 2014
Enrollment StartSep 1, 2014
Primary CompletionDec 1, 2015
Study CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 11.9 years ago

Interventions

Restylane Perlanedevice

Intradermal injection